Ligand Announces Positive Regulatory Opinion in Europe for Revolade for Chronic Immune Thrombocytopenic Purpura December 18, 2009
Ligand Presents New Preclinical Data on its Lead SARM Molecule LGD-4033 at the Gerontological Society of America Annual Meeting November 20, 2009
Ligand to Present on October 6th at the Fourth Annual JMP Securities Healthcare Focus Conference September 30, 2009